The Effect of Doxycycline on the Expression of MMP-2 and MMP-9 in Multiple Myeloma.
10.19746/j.cnki.issn.1009-2137.2022.02.027
- Author:
Yuan-Lin YANG
1
;
Li-Xia WANG
2
;
Xiao-Ming FEI
1
;
Fang LEI
1
;
Wen-Ping LU
1
;
Xian-Qiu YU
1
;
Shuo ZHANG
1
Author Information
1. Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, Jiangsu Province, China.
2. Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, Jiangsu Province, China,E-mail: jhhfly@126.com.
- Publication Type:Journal Article
- Keywords:
MMP-2;
MMP-9;
doxycycline;
multiple myeloma;
serine/threonine kinase Akt
- MeSH:
Doxycycline/pharmacology*;
Humans;
Matrix Metalloproteinase 2/metabolism*;
Matrix Metalloproteinase 9/metabolism*;
Multiple Myeloma/metabolism*;
Proto-Oncogene Proteins c-akt
- From:
Journal of Experimental Hematology
2022;30(2):487-492
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the expression of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in multiple myeloma (MM) patients, and analyze the effect of doxycycline (DOX) on the expression of MMP-2 and MMP-9 in MM cells.
METHODS:The peripheral blood and bone marrow samples of MM patients were collected, and the patients were divided into three groups: newly diagnosed group, remission group and relapsed/refractory group, while the peripheral blood samples of 34 health people and the bone marrow samples of 17 IDA patients were selected as normal control and control group. The levels of MMP-2 and MMP-9 were detected by ELISA. The protein levels of MMP-2 and MMP-9 in H929 cells treated by different concentrations of DOX were analyzed by Western blot. After H929 cells was treated by Akt inhibitor MK-2206 2HCl in combination with DOX, Western blot was used to detect the levels of MMP-2 and MMP-9.
RESULTS:The levels of MMP-2 and MMP-9 in newly diagnosed MM patients were higher than those in control (P<0.05), while for the patients in the remission group were decreased, but still higher than those in control. The levels of MMP-2 and MMP-9 were increased again for the patients in relapsed/refractory group, and showed no significant difference as compared with those in newly diagnosed group. The levels of MMP-2 and MMP-9 could be inhibited by 10 mg/L and 15 mg/L DOX treated by H929 cell. The protein levels of MMP-2 and MMP-9 showed no altered in H929 cells treated by 5 nmol/L MK-2206 2HCl alone. DOX exerted more profound inhibitory effect to MMP-2 and MMP-9 expression in H929 cells when Akt inhibitor MK-2206 2HCl was combined with DOX.
CONCLUSION:The levels of MMP-2 and MMP-9 are increased in MM patients and related to the disease status of MM. DOX can inhibit the expression of MMP-2 and MMP-9 in MM cells, and antagonizing its activation of Akt signaling pathway can further enhance the inhibitory effect.
